Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase 3 1Phase 2 1

Status

Unknown 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Carcinoma, Hepatocellular 3Recurrence 1Liver Neoplasms 1Hepatitis B 1

Interventions

Oxaliplatin 21Capecitabine 19Fluorouracil 16Bevacizumab 16Esomeprazole 11Sorafenib 10Irinotecan 9Leucovorin 8Radiofrequency Ablation 7Propofol 7Bismuth 7Morphine 6Gemcitabine 6Folfox protocol 6Amoxicillin 6lenvatinib 5gadolinium ethoxybenzyl DTPA 5Tetracycline 5Sevoflurane 5S 1 (combination) 5Drug Therapy 5Control Groups 5Cisplatin 5sodium glycididazole 4fish oil triglycerides 4ferric carboxymaltose 4Sodium Chloride 4Ropivacaine 4Ribavirin 4Hepatectomy 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Lamivudine × Gastrointestinal × Clear all
NCT01894269 2013-07-23

Chemoembolization With or Without Antiviral Therapy for Unresectable HBV-related HCC With Low HBV DNA Replication

Sun Yat-sen University

Phase 4 Unknown
200 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT00555334 2009-04-01

LAM-RFA

Sun Yat-sen University

Phase 4 Unknown
200 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00768157 2009-02-09

Efficacy of Antiviral Therapy After Radical Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma

Sun Yat-sen University

Phase 4 Unknown
200 enrolled
Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡